logo
Select company
Select metric
$ -111.45MEarning Before Interest & Taxes (EBIT)
VS
Market
9
Sector
18
Industry
26
History
33
$ 2.37Close
$ 1.1 - $ 6.45 52-Week Range
Ticker Information

Ticker

CCCC

Company Name

C4 THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

C4 THERAPEUTICS INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CCCC - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -111.45M
3/31/2025$ -103.15M
12/31/2024$ -105.19M
9/30/2024$ -105.22M
6/30/2024$ -106.42M
3/31/2024$ -124.03M
12/31/2023$ -129.84M
9/30/2023$ -131.95M
6/30/2023$ -137.48M
3/31/2023$ -129.04M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • C4 THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT stands at $ -65.73M.
  • Over the past 5 years, C4 THERAPEUTICS INC's average EBIT has been $ -106.88M.
  • The median EBIT for C4 THERAPEUTICS INC during this period was $ -105.2M
  • C4 THERAPEUTICS INC reached its highest EBIT over the past 5 years at $ -65.73M.
  • The lowest EBIT recorded by C4 THERAPEUTICS INC in the same timeframe $ -137.48M

C4 THERAPEUTICS INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
VYGR : VOYAGER THERAPEUTICS INC $ -107.25MEDIT : EDITAS MEDICINE INC $ -242.16MFENC : FENNEC PHARMACEUTICALS INC $ -8.49MOABI : OMNIAB INC $ -68.37MMGX : METAGENOMI INC $ -90.29MTLSI : TRISALUS LIFE SCIENCES INC $ -26.33MSPRO : SPERO THERAPEUTICS INC $ -53.6MCELU : CELULARITY INC $ -65.72MUTMD : UTAH MEDICAL PRODUCTS INC $ 15.49MIVVD : INVIVYD INC $ -110.13M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

CCCC - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -137.48M

Minimum

Jun 30, 2023

$ -65.73M

Maximum

Dec 31, 2020

$ -106.88M

Average

$ -105.2M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.62M with a standard deviation of $ 130.62M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 442.4M
average$ 28.62M
median$ 897.02K
std$ 130.62M